Tissue targeting in cancer: eIF4E's tale

Clinical Cancer Research

Volumn 15, Issue 13, 2009, Pages 4254-4255

  Borden, Katherine L B ^a  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTISENSE OLIGONUCLEOTIDE; CISPLATIN; CYCLIN D1; GONADORELIN AGONIST; GONADOTROPIN RECEPTOR STIMULATING AGENT; HORMONE RECEPTOR STIMULATING AGENT; HYBRID PROTEIN; INITIATION FACTOR 4E; INITIATION FACTOR 4E BINDING PROTEIN 1; INITIATION FACTOR 4G; MESSENGER RNA; PROTEIN MDM2; RIBAVIRIN; UNCLASSIFIED DRUG; VASCULOTROPIN;

ACUTE GRANULOCYTIC LEUKEMIA; ARTICLE; CANCER CELL CULTURE; CLINICAL TRIAL; COMPLEX FORMATION; DRUG TARGETING; GENE EXPRESSION REGULATION; HUMAN; INTRACELLULAR TRANSPORT; MALIGNANT TRANSFORMATION; NONHUMAN; OVARY CANCER; PRIORITY JOURNAL; PROGNOSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; PROTEIN PROTEIN INTERACTION; REGULATORY MECHANISM; TISSUE SPECIFICITY; TRANSLATION REGULATION;

ANIMALS; ANTINEOPLASTIC AGENTS; DRUG DELIVERY SYSTEMS; EUKARYOTIC INITIATION FACTOR-4E; FEMALE; GONADOTROPIN-RELEASING HORMONE; HUMANS; MICE; MICE, KNOCKOUT; MODELS, BIOLOGICAL; OVARIAN NEOPLASMS; RECOMBINANT FUSION PROTEINS; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 67650351089     PISSN: 10780432     EISSN: None     Source Type: Journal    
DOI: 10.1158/1078-0432.CCR-09-0552     Document Type: Article

References (13)

1. Ko S,Gu o H, Barengo B,N aora H. Inhibition of ovarian cancer growth by a tumor-targeting peptide that binds the eukaryotic translation initiation factor 4E. Clin Cancer Res 2009;15:4336-47. doi:10.1158/1078-0432.CCR-08-1332.
2. Graff JR,Z immer SG. Translational control and metastatic progression: enhanced activity of the mRNA cap-binding protein eIF-4E selectively enhances translation of metastasis-related mRNAs. Clin Exp Metastasis 2003;20:265-73. PubMed doi:10.1023/A:1022943419011.
3. Culjkovic B,Topisirovic I, Borden KL. Controlling gene expression through RNA regulons: the role of the eukaryotic translation initiation factor eIF4E. Cell Cycle 2007;6:65-9. PubMed.
4. Rong L,L ivingstone M,S ukarieh R,e t al. Control of eIF4E cellular localization by eIF4E-binding proteins, 4E-BPs. RNA 2008; 14: 1318-27. PubMed doi:10.1261/rna.950608.
5. Blackshear PJ,S tumpo DJ,Ca rballo E, Lawrence JC,Jr. Disruption of the gene encoding the mitogenregulated translational modulator PHAS-I in mice. J Biol Chem 1997; 272: 31510-4. PubMed doi:10.1074/jbc.272.50.31510.
6. Graff JR,K onicek BW, Vincent TM, et al. Therapeutic suppression of translation initiation factor eIF4E expression reduces tumor growth without toxicity. J Clin Invest 2007;117:2638-48. PubMed doi:10.1172/JCI32044.
7. Kentsis A,Topisirovic I,C uljkovic B,S hao L, Borden KL. Ribavirin suppresses eIF4E-mediated oncogenic transformation by physical mimicry of the 7-methyl guanosine mRNA cap. Proc Natl Acad Sci U S A 2004; 101: 18105-10. PubMed doi :10.1073/pnas.0406927102.
8. Assouline S,C uljkovic B,Coc olakis E, et al.Molecular targeting of the oncogene eIF4E in AML: a proof-ofprinciple clinical trial with ribavirin. Blood May 11, 2009. Epub ahead of print. PMID: 19433856.
9. Oridate N,K im HJ, Xu X,Lo tan R. Growth inhibition of head and neck squamous carcinoma cells by small interfering RNAs targeting eIF4E or cyclin D1alone or combined with cisplatin. Cancer Biol Ther 2005;4: 318-23. PubMed.
10. Dong K,Wang R,Wang X, et al.Tumor-specific RNAi targeting eIF4E suppresses tumor growth,i nduces apoptosis and enhances cisplatin cytotoxicity in human breast carcinoma cells. Breast Cancer Res Treat 2009;113:443-56. PubMed doi:10.1007/s10549-008-9956-x.
11. Siegele B,Cef alu C, Holm N,et al. eIF4E-targeted suicide gene therapy in a minimal residual mouse model for metastatic soft-tissue head and neck squamous cell carcinoma improves disease-free survival. J Surg Res 2008;148:83-9. PubMed doi:10.1016/j.jss.2008.03.011.
12. Armengol G,R ojo F,Cas tellvi J, et al. 4E-binding protein 1: a key molecular funnel factor in human cancer with clinical implications. Cancer Res 2007; 67:7551-5. PubMed doi:10.1158/0008-5472.CAN-07-0881.
13. Salehi Z,M ashayekhi F. Expression of the eukaryotic translation initiation factor 4E (eIF4E) and 4EBP1 in esophageal cancer. Clin Biochem 2006;39: 404-9. PubMed doi:10.1016/j.clinbiochem.2005. 11.007.